NEW YORK — In the landscape of public health and hereditary cancer advocacy, the transition from supporter to patient is a journey few anticipate. For Lizzy Burke, a health policy staffer for U.S. Senate Democratic Leader Chuck Schumer, that transition was a decade in the making. What began as a collegiate commitment to a sorority’s philanthropic cause evolved into a personal battle for survival, a series of life-altering surgeries, and a professional mission to influence national health policy.
As Burke prepares for the 2026 TCS New York City Marathon with Team Sharsheret, her story serves as a profound case study in the efficacy of early education, the psychological weight of genetic testing, and the critical role of community-based support systems in the American healthcare continuum.
The Foundation: Campus Awareness and Family Legacy
The seeds of Burke’s advocacy were sown in 2014 at Boston University. Upon joining the Epsilon Eta chapter of Alpha Epsilon Phi (AEPhi), she was introduced to Sharsheret, a national non-profit organization dedicated to supporting Jewish women and families facing breast and ovarian cancer.
The mission resonated deeply with Burke due to her family’s medical history. Her mother had been diagnosed with breast cancer at the age of 42—a common red flag for hereditary mutations. While her mother has remained in remission for over two decades, the specter of the disease remained a constant in their family narrative.
“As a college student, I was proud to support Sharsheret’s mission through AEPhi’s philanthropic efforts,” Burke noted. “I never imagined that years later, I would turn to the very organization I had learned about on campus for support during one of the most difficult chapters of my own life.”
This "full-circle" phenomenon is a cornerstone of Sharsheret’s outreach strategy. By targeting collegiate populations through partnerships with organizations like AEPhi, the organization ensures that young women at high risk—particularly those of Ashkenazi Jewish descent—are equipped with knowledge long before they enter the clinical environment.
Chronology of a Previvor: From Marathon to Mastectomy
Burke’s engagement with the cause intensified in 2018 when she and her sister, Maggie, ran the New York City Marathon as part of Team Sharsheret. At the time, she was an athlete running for a cause; two years later, she would become the cause herself.
In 2020, amid a global pandemic, Burke underwent genetic testing. The results confirmed her status as a "previvor"—an individual who has not been diagnosed with cancer but carries a genetic mutation that significantly increases their risk. Burke tested positive for the BRCA1 gene mutation.
According to clinical data, women with a BRCA1 mutation have up to a 72% lifetime risk of developing breast cancer and a 44% risk of developing ovarian cancer. For Burke, the "educational conversations" of her sorority days were suddenly transformed into a roadmap for surgical intervention.
The ensuing four years were defined by a series of high-stakes medical decisions. In the fall of 2024, at an age similar to when her mother was first diagnosed, Burke underwent a prophylactic double mastectomy. This risk-reducing surgery, while effective in lowering breast cancer risk by over 90%, carries significant physical and emotional trauma, especially for young women navigating their careers and personal lives.
Supporting Data: The Genetic Link and the "1 in 40" Statistic
Burke’s story highlights a critical demographic reality in oncology. While approximately 1 in 400 people in the general population carry a BRCA1 or BRCA2 mutation, the prevalence among individuals of Ashkenazi Jewish descent is 1 in 40. This ten-fold increase in risk necessitates specialized outreach and tailored support systems.
| Statistic | General Population | Ashkenazi Jewish Population |
|---|---|---|
| BRCA Mutation Prevalence | 1 in 400-500 | 1 in 40 |
| Lifetime Breast Cancer Risk (BRCA1) | ~12% | Up to 72% |
| Lifetime Ovarian Cancer Risk (BRCA1) | ~1.3% | Up to 44% |
Sharsheret’s role in this ecosystem is to bridge the gap between clinical data and the human experience. During Burke’s recovery, the organization provided more than just information. They facilitated peer-to-peer connections with other young "previvors" and sent "care kits" designed to manage the physical discomfort of post-surgical drains and recovery.
“Support isn’t just about resources,” Burke emphasized. “It’s about knowing someone understands. When I faced unexpected complications during recovery, Sharsheret reminded me I wasn’t facing this journey alone.”
Official Responses and the Role of Sharsheret
Sharsheret, which means "chain" in Hebrew, operates on the philosophy that a community of support can sustain an individual through the most isolating moments of a diagnosis.
In a statement regarding the importance of the AEPhi partnership, Sharsheret’s leadership noted: "The connection between AEPhi and Sharsheret is more than a philanthropic endeavor; it is a lifeline. By educating women in their early twenties, we are providing them with the tools to manage their health proactively. Lizzy Burke’s journey from a student volunteer to a resilient advocate embodies the very essence of our mission."
Medical professionals also stress the importance of organizations like Sharsheret in the "shared decision-making" process. Prophylactic surgeries are elective but medically indicated for mutation carriers; the psychological preparation provided by non-clinical support groups is often cited as a key factor in successful long-term patient outcomes.
From Personal Trauma to Public Policy
While her personal life was dominated by recovery, Burke’s professional life was centered on the broader implications of healthcare access. Serving as a health policy advisor for Senate Democratic Leader Chuck Schumer, Burke occupies a unique vantage point where personal experience meets legislative action.
Her work involves navigating the complexities of the American healthcare system, focusing on how information, care, and support can be made accessible to all citizens. Her journey has underscored the necessity of policies that protect genetic privacy and ensure that genetic testing and preventative surgeries are covered by insurance providers—issues addressed by the Genetic Information Nondiscrimination Act (GINA) and the Affordable Care Act (ACA).
“Every day, I’m reminded how important access to information, care, and support can be in helping people make informed decisions about their health,” Burke said. Her role in Senator Schumer’s office allows her to advocate for the funding of cancer research and the expansion of screening programs that save lives.
Implications: The 2026 Marathon and Beyond
In November 2026, Burke will return to the streets of New York City to run the marathon for a second time. This race, however, carries a different weight than the one she ran in 2018. It is a celebration of her health, a tribute to her mother’s resilience, and a fundraising effort to ensure Sharsheret can continue its work for the next generation of women.
The implications of Burke’s story reach far beyond the Jewish community or AEPhi alumni. It serves as a call to action for:
- Early Education: The importance of introducing health literacy and genetic awareness at the collegiate level.
- Comprehensive Support: Recognizing that medical intervention must be supplemented by emotional and peer-based care.
- Policy Advocacy: Utilizing personal health narratives to drive legislative changes that prioritize preventative care.
As Burke approaches the 26.2-mile challenge, her focus remains on the "chain" of support that carried her from a sorority house in Boston to the halls of the U.S. Capitol.
“Every mile I run this November is a thank you to the organization that stood beside me and a reminder that awareness truly saves lives,” Burke concluded. “Together, we can help ensure that no one facing breast cancer or ovarian cancer, or an inherited cancer risk, has to navigate it alone.”
The 2026 TCS New York City Marathon will feature thousands of runners, but few will embody the intersection of philanthropy, survival, and policy as clearly as Lizzy Burke. Her journey reinforces a vital truth in modern medicine: while genetics may provide the map, it is the community that provides the strength to complete the race.
About the Author
